A
Asepha Prism • Enterprise Console
Demo:
High Exposure

Network DIR / True-Up Forecast

Real-time exposure visibility across your PSAO network

Projected POS Withholds

$18,200,000

Expected Net Loss After True-Up

$15,500,000

Peer Benchmark Position

-12%

below national avg

Member Pharmacies

2,500

PBM Comparison (DIR % vs Exposure)
PBM Summary
PBMStoresPDCGDRSUPDHealthAction
CVS Caremark8405.8%$9.2M78.5%82.3%71.2%62View Details
OptumRx5605.1%$5.7M85.1%89.5%81.2%78View Details
Humana4406.3%$4.8M76.2%80.1%68.5%55View Details
Express Scripts3905.5%$4.1M83.5%87.2%78.3%70View Details
Prime2705.0%$2.3M87.8%91.3%84.5%80View Details
Aetna1905.4%$1.6M81.2%85.1%74.8%73View Details
Forecast Over Time
Monthly DIR percentage and withhold projections
Risk by State/Region
Geographic distribution of DIR exposure

TX

450 pharmacies

Avg DIR: 6.8%

High

CA

380 pharmacies

Avg DIR: 6.5%

High

FL

320 pharmacies

Avg DIR: 5.9%

Medium

NY

290 pharmacies

Avg DIR: 5.7%

Medium

PA

260 pharmacies

Avg DIR: 5.2%

Low

OH

240 pharmacies

Avg DIR: 5.0%

Low

IL

220 pharmacies

Avg DIR: 5.8%

Medium

GA

200 pharmacies

Avg DIR: 6.3%

High
Pharmacy Risk Summary
Click any row to view detailed snapshot
PharmacyPOS WithholdsExpected True-UpRisk
Riverside Pharmacy78.5%82.3%71.2%6.8%$85,000$18,200High
Oakwood Drugs81.2%85.1%74.8%6.2%$72,000$14,500High
Maple Street Pharmacy83.5%87.2%78.3%5.8%$65,000$11,200Medium
Central Care Pharmacy85.1%89.5%81.2%5.4%$58,000$9,800Medium
Wellness Pharmacy87.8%91.3%84.5%5.0%$52,000$7,500Low
Negotiation Readiness
Top clauses driving exposure
  • Adherence <85% triggers 7% DIR withhold
  • GDR <90% adds 2% additional withhold
  • Statin-in-Diabetics <80% adds 3% withhold
  • Quality bonus only applies at 4.5+ stars
Peer Benchmark
National cohort comparison
Top Quartile3.8% DIR
Median5.2% DIR
Bottom Quartile7.1% DIR
Exec Notes
Private notes and observations